WO2002077073A2 - Plastic articles having a polyphosphazene coating - Google Patents
Plastic articles having a polyphosphazene coating Download PDFInfo
- Publication number
- WO2002077073A2 WO2002077073A2 PCT/EP2002/003268 EP0203268W WO02077073A2 WO 2002077073 A2 WO2002077073 A2 WO 2002077073A2 EP 0203268 W EP0203268 W EP 0203268W WO 02077073 A2 WO02077073 A2 WO 02077073A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coating
- plastic
- plastic substrate
- polymer
- adhesion promoter
- Prior art date
Links
- 229920003023 plastic Polymers 0.000 title claims abstract description 98
- 239000004033 plastic Substances 0.000 title claims abstract description 98
- 238000000576 coating method Methods 0.000 title claims abstract description 50
- 239000011248 coating agent Substances 0.000 title claims abstract description 49
- 229920002627 poly(phosphazenes) Polymers 0.000 title abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 10
- 239000000758 substrate Substances 0.000 claims description 52
- 229920000642 polymer Polymers 0.000 claims description 22
- 239000002318 adhesion promoter Substances 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- -1 polyethylene terephthalates Polymers 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000001072 heteroaryl group Chemical group 0.000 claims description 8
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 7
- 125000004104 aryloxy group Chemical group 0.000 claims description 7
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 7
- 239000010410 layer Substances 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- 239000012298 atmosphere Substances 0.000 claims description 4
- 239000011261 inert gas Substances 0.000 claims description 4
- 238000009832 plasma treatment Methods 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 4
- 238000005238 degreasing Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- BYIMSFXYUSZVLI-UHFFFAOYSA-N 3-methoxysilylpropan-1-amine Chemical group CO[SiH2]CCCN BYIMSFXYUSZVLI-UHFFFAOYSA-N 0.000 claims 1
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 6
- 239000007943 implant Substances 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ZQBFAOFFOQMSGJ-UHFFFAOYSA-N hexafluorobenzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1F ZQBFAOFFOQMSGJ-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- 241000912781 Carcharhinus galapagensis Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000004915 dibutylamino group Chemical group C(CCC)N(CCCC)* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D185/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Coating compositions based on derivatives of such polymers
- C09D185/02—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon; Coating compositions based on derivatives of such polymers containing phosphorus
Definitions
- the present invention relates to plastic articles having a coating which comprises polyphosphazene derivatives, a process for their production as well as the use as a wound coverage having excellent biological and pharmaceutical properties.
- the coating of plastics with other plastics has been hitherto achieved with a variety of plastics, especially with the aim, on the one hand, to maintain the properties of the plastics which serve as a substrate, and, on the other hand, to change and to optimise the surface properties of said plastics by applying a coating comprised of another plastic, on the surface thereof.
- problems may arise, particularly based on the chemical and physical behaviour and the adhesion of the different plastics among each other.
- miscibility gaps might be created from co-extrusion of two different plastics, which gives the desired arrangement of the plastics - i.e. one plastic as the substrate strictcore", and another plastic used for coating applied on the substrate, but in this case the adhesion of the plastics among each other is negatively affected.
- plastics from solvents i.e. plastics in solution
- reasons, not trivial as well and there must be carried out a huge amount of series of experiments to find appropriate solvents and solvent systems which, on the one hand, do not or substantially not change the properties of the plastic which serves as substrate, for example to maintain the desired elasticity, and, on the other hand, to solve the other plastic which is used for coating or for modifying the surface.
- a lot of effort is necessary when a strong adhesion of different plastics among each other should be achieved, since the evaporation of the solvent might result in the phenomenon of phase separation, and thereby the loss of a permanent and durable adhesion might arise.
- the coating of plastics is desirable, since the plastics used for the coating often exhibit properties which cannot be achieved with the hitherto used and above mentioned plastics.
- the polymeric compound poly[bis(trifluoroethoxy)phosphazene] exhibits good antithrombogenic action as a filler (see Tur, füren zur Thrombenresistenz von Poly[bis(trifluoroethoxy)phosphazen] [Studies of resistance of poly[bis(trifluoroethoxy)phosphazene] to thrombus formation] and Hollemann Wiberg, "Stickstoff für Phosphors" [Nitrogen compounds of phosphorus], Lehrbuch der anorganischen Chemie [Textbook of Inorganic Chemistry], 666-669, 91st-100th Edition, Walter de Gruyter Verlag, 1985; and Tur, Vinogradova et al., "Entwicklungstendenzen bei polymeranalogen tighten von Polyphosphazenen” [Trends in development of polymer-like reactions of polyphosphazenes], Acta Polymerica 39, No. 8, 424-429 (1988)). Further, polyphosphazen
- the known coating methods are not suitable for applying polyphoshazene derivatives, particularly poly[bis(trifluoroethoxy)phosphazene] on the surface of common plastics and thereby imparting said plastic surfaces and the articles made therefrom the positive and desirable properties of said polyphosphazene derivatives.
- the polyphosphazene derivatives mentioned in DE 196 13 048 can be prepared only with a high experimental input, but do not exhibit, as a volume material, the mechanical properties which can be achieved with other plastics, such as hardness etc., and are very expensive due to the preparation method.
- the technical problem underlying the present invention is to provide a new system and a method for coating commonly used plastics with polyphosphazene derivatives, wherein the coating should not negatively affect the mechanical properties of said plastics used as the substrate, particularly should not change or destroy said properties, and the coating of the polyphosphazene derivative should exhibit a high adhesion and bonding to the plastics used as substrate without negatively affecting or destroying the properties of the polyphosphazene derivative to be used as a constituent of the coating.
- n is from 2 to ⁇ ,
- R 1 to R 6 are the same or different and represent an alkoxy, alkylsulfonyl, dialkylamino or aryloxy group, or a heterocycloalkyl or heteroaryl group in which nitrogen is the heteroatom.
- the coating can be applied to any plastic substrate.
- the term “antimony oxide” encompasses any commonly used plastic without any particular limitation. Examples of plastic substrates are polyethylene therephthalates, polyurethanes, polyethylenes, polyvinylchlorides and silicones.
- the term drawnplastic article includes any plastic articles without any particular limitation of the form or shape.
- said plastic article encompasses artificial implants such as plastic implants for e.g. breast, nose or ear, bone nails, bone screws, bone plates, artificial (urinary) bladder, artificial cartilage, dental implants, artificial bones for e.g. artificial hip or hip joints, artificial esophagus and artificial trachea; artificial (arterial and veinous) blood vessels; stents such as urological stents and cardiovascular stents; catheters such as urological catheters and cardiovascular catheters; cardiovascular grafts; emplastrums; dermatoplasties; devices, e.g.
- therapeutic devices such as cardiac pacemakers, defibrillators, electrodes for cardiac pace- makers and defibrillators, surgical devices, surgical instruments, artificial biological membrans and artificial organs such as artificial kidneys and artificial heart, and, in a preferred embodiment, wound coverages.
- the degree of polymerization of the polymer used in the coating according to the present invention can be from 2 to ⁇ . However, the preferred range for the degree of polymerization is from 20 to 200,000, and more preferably 40 to 100,000.
- At least one of the groups R 1 to R 6 in the polymer used is an alkoxy group substituted with at least one fluorine atom.
- alkyl groups in the alkoxy, alkylsulfonyl and dialkylamino groups are, for example, straight or branched alkyl groups with 1 to 20 carbon atoms, in which the alkyl groups can, for example, be substituted with at least one halogen atom, such as a fluorine atom.
- alkoxy groups are the methoxy, ethoxy, propoxy and butoxy groups, which can preferably be substituted with at least one fluorine atom.
- the 2,2,2- trifluoroethoxy group is particularly preferred.
- alkylsulfonyl groups are methylsulfonyl, ethylsulfonyl, propylsulfonyl and butylsulfonyl groups.
- dialkylamino groups are dimethylamino, diethylamino, dipropylamino and dibutyl- amino groups.
- the aryl group in the aryloxy group is, for example, a compound with one or more aromatic ring systems, in which the aryl group can, for example, be substituted with at least one alkyl group as previously defined.
- aryloxy groups are the phenoxy and naphthoxy groups and their derivatives.
- the heterocycloalkyl group is, for instance, a ring system containing 3 to 7 atoms, with at least one ring atom being a nitrogen atom.
- the heterocycloalkyl group can, for example, be substituted with at least one alkyl group as previously defined.
- Examples of heterocycloalkyl groups are the piperidinyl, piperazinyl, pyrrolidinyl and morpholinyl groups and their derivatives.
- the heteroaryl group is, for example, a compound with one or more aromatic ring systems in which at least one ring atom is a nitrogen atom.
- the heteroaryl group can, for example, be substituted with at least one alkyl group as previously defined.
- Examples of heteroaryl groups are the pyrrolyl, pyridinyl, pyridinolyl, isoquinolinyl and quinolinyl groups and their derivatives.
- the coating of the plastic article of the present invention has preferably a thickness ranging from a monolayer comprised of polymer (I) to about 20 ⁇ m, more preferably from about 1 nm to about 10 ⁇ m, and particularly preferably up to about 3 ⁇ m.
- the coating of the plastic article comprises a 32 P-, 33 P- or As or Sb-isotope labelled poly[bis(trifluoroethoxy)phosphazene].
- a layer containing an adhesion promoter is provided between the surface of the plastic substrate and the coating containing the polyphosphazene derivative of formula (I).
- the adhesion promoter or spacer contains a polar end group.
- a polar end group examples are hydroxy groups, carboxy groups, carboxyl groups, amino groups or nitro groups, but end groups of the O-ED type can also be used, wherein O-ED represents an alkoxy, alkylsulfonyl, dialkylamino or aryloxy group, or a heterocycloalkyl or heteroaryl group in which nitrogen is the heteroatom, and can have different substitutents like halogen atoms, particularly fluorine atoms.
- the adhesion promoter is, for example, a silicium-organic compound, preferably an amino-terminated silane or based on aminosilane, amino-terminated alkenes, nitro-terminated alkenes and silanes, or an alkylphosphonic acid.
- Aminopropyltrimethoxysilane is particularly preferred.
- the adhesion promoter particularly improves adhesion of the coating to the surface of a plastic substrate by coupling the adhesion promoter to the surface of the plastic substrate, for instance by ionic and/or covalent bonds and by further coupling of the adhesion promoter to reactive components, particularly to the above described polymer with the general formula (I) of the coating, for instance, through ionic and/or covalent bonds.
- step (c) pulling out and drying the plastic substrate coated with said polymer on air or in an inert gas atmosphere.
- step (a) of the process according to the present invention the plastic substrate to be coated should be degreased in order to provide a good adhesion between the coating and surface of the plastic substrate.
- the plastic article should be further sterilised.
- the agents used for degreasing and/or sterilisation should not dissolve or attack the plastic substrate.
- step (b) the polymer, preferably poly[bis(trifluoroethoxy)polyphosphazene], is dissolved in a suitable solvent in a concentration of from about 0.01 to about 5 g/100 ml, preferably 0.01 to 3 g/100 ml.
- suitable solvent include acetone, tetrahydrofuran, ethylacetate, methylethylketon, cyclohexanone, hexafluorobenzene and mixtures thereof.
- the immersion of the plastic substrate into the solution of said polymer can be carried out with any suitable means, for example semi-automatically or automatically, and does not exhibit any limitation.
- the time period of immersion is dependent on the solvent or solvent mixture used and on the plastic substrate, i.e. the resin constituents, used, and may range from 1 second to several hours, during which the polymer molecules are deposited on the surface of the plastic substrate.
- the rate of the pulling or drawing out of the coated plastic substrates from the polymer solution is not specifically limited, but may depend on the plastic substrate used and its shape, and on pressure and temperature conditions such as standard pressure and room temperature. For instance, in case of hoses, the rate of pulling out is about 10 cm/min.
- Drying of the coated plastic substrates is carried out on air or in an inert gas atmosphere, such as argon or nitrogen. The drying can last from about 1 second to several hours, dependent on temperature, solvent, and plastic substrate used.
- a complete drying of the coated plastic substrates on air or in an inert gas atmosphere is preferred, in order to remove residual solvent, if present. Depending on the plastic substrate and solvent or solvent mixture used, the complete drying may require up to several days. It is also possible to remove the solvent or residual of solvents under vacuum.
- an adhesion promoter as defined above can be applied to the surface of the plastic substrate prior to step (b) of the process of the present invention.
- step (b) of the process of the present invention it is also possible to subject the plastic substrate to a plasma treatment prior to step (b) of the process of the present invention in order to improve adhesion of the coating to the surface of the plastic substrate.
- firstly a plasma treatment and secondly the application of an adhesion promoter can be carried out prior to step (b) of the process of the present invention.
- the coating of the adhesion promoter can be carried out with any method known in the prior art, such as solvent coating, vapour deposition etc.
- the plastic article can also be provided with a microstructure in the coating.
- the sizes of such microstructures do not exhibit any limitation, and can have sizes from a few nanometres up to several micrometers or even more.
- the microstructures can be applied by any method known in the art, such as photolithography or using electron radiation or ion radiation or using a laser.
- Microstructures of the coated plastic substrates can also be obtained by using direct ..writing" on the plastic substrates by means of a laser, electron radiation or X-ray.
- the microstructures can be obtained by so-called melt structuring, in which a thin wire is heated on the melting temperature of the polymer, said wire is melting the desired structure in the plastic substrate by direct contact.
- melt structuring in which a thin wire is heated on the melting temperature of the polymer, said wire is melting the desired structure in the plastic substrate by direct contact.
- a specific embodiment of the present invention is a wound coverage comprising at least one layer having a coating containing the above polymer (I), wherein said coating is in contact with the wound such as a burn wound, of a patient in need thereof.
- the coating which is in contact with the wound of a patient imparts excellent properties such as biobompatibility, anti-inflammatory effects etc. to the wound coverage, which is based on the polymer (I) used in the coating.
- the wound coverage of the present invention can be built up as a two-layered structure, i.e. the plastic substrate and the coating, or three or more layered structure (..multi-layer structure").
- the wound coverage of the present invention should be preferably gas( administratair")-permeable, i.e. a porous wound coverage. This is achieved by providing e.g. a porous plastic substrate having pore sizes of from about a few nanometers, e.g. 5 nm, to about 30 ⁇ m, and a coating and optionally further layers which also exhibit pores comparable to the pores of the plastic substrate, for the gas-exchange.
- a specifically advantageous property of the wound coverage of the present invention is that the freshly formed cellular tissue or fibrous tissue originating from the wound, does not adhere or infiltrate the coating of said wound coverage.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Paints Or Removers (AREA)
- Materials For Medical Uses (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002310973A AU2002310973A1 (en) | 2001-03-22 | 2002-03-22 | Plastic articles having a polyphosphazene coating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2001113971 DE10113971A1 (en) | 2001-03-22 | 2001-03-22 | Process for coating plastic surfaces with bis-poly-trifluoroethoxy-polyphosphazene and derivatives |
DE10113971.3 | 2001-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002077073A2 true WO2002077073A2 (en) | 2002-10-03 |
WO2002077073A3 WO2002077073A3 (en) | 2003-02-06 |
Family
ID=7678529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/003268 WO2002077073A2 (en) | 2001-03-22 | 2002-03-22 | Plastic articles having a polyphosphazene coating |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002310973A1 (en) |
DE (1) | DE10113971A1 (en) |
WO (1) | WO2002077073A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008045953A3 (en) * | 2006-10-10 | 2009-10-08 | Celonova Biosciences, Inc. | Compositions and devices comrising silicone and specific polyphosphazenes |
WO2009105761A3 (en) * | 2008-02-22 | 2009-11-26 | Celonova Biosciences, Inc. | Multi-functional wound dressing matrices and related methods |
WO2010036257A1 (en) * | 2008-09-25 | 2010-04-01 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
US8007821B2 (en) | 2001-01-11 | 2011-08-30 | Celonova Biosciences Germany Gmbh | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface |
US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4311736A (en) * | 1979-03-19 | 1982-01-19 | The Kendall Company | Article having organo-phosphonitrile rubber coating bonded to natural or synthetic rubber and method of making |
US4341844A (en) * | 1979-10-25 | 1982-07-27 | The Kendall Company | Article having organo-phosphonitrile rubber coating bonded to natural or synthetic rubber and method of making |
US4728345A (en) * | 1983-12-28 | 1988-03-01 | Monsanto Company | Multicomponent gas separation membranes having polyphosphazene coatings |
JPH04120900A (en) * | 1990-09-11 | 1992-04-21 | Onkyo Corp | Diaphragm for loudspeaker |
FR2679466B1 (en) * | 1991-07-25 | 1994-04-15 | Ceramique Technique | FILTRATION MEMBRANE AND MANUFACTURING METHOD. |
DE19613048C2 (en) * | 1995-03-30 | 1997-12-18 | Michael Prof Dr Grunze | Artificial implants with antithrombogenic properties and processes for their production |
DE19743373A1 (en) * | 1997-09-30 | 1999-04-15 | Univ Heidelberg | · 3 ·· 2 · P-polyphosphazene |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
EP1265653B1 (en) * | 2000-03-18 | 2004-06-02 | Polyzenix GmbH | Use of polyphosphazene derivatives for antibacterial coatings |
-
2001
- 2001-03-22 DE DE2001113971 patent/DE10113971A1/en not_active Withdrawn
-
2002
- 2002-03-22 AU AU2002310973A patent/AU2002310973A1/en not_active Abandoned
- 2002-03-22 WO PCT/EP2002/003268 patent/WO2002077073A2/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8007821B2 (en) | 2001-01-11 | 2011-08-30 | Celonova Biosciences Germany Gmbh | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface |
US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
WO2008045953A3 (en) * | 2006-10-10 | 2009-10-08 | Celonova Biosciences, Inc. | Compositions and devices comrising silicone and specific polyphosphazenes |
WO2009105761A3 (en) * | 2008-02-22 | 2009-11-26 | Celonova Biosciences, Inc. | Multi-functional wound dressing matrices and related methods |
US20100047324A1 (en) * | 2008-02-22 | 2010-02-25 | Celonova Biosciences, Inc. | Multi-Functional Wound Dressing Matrices and Related Methods |
WO2010036257A1 (en) * | 2008-09-25 | 2010-04-01 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
Also Published As
Publication number | Publication date |
---|---|
DE10113971A1 (en) | 2002-10-24 |
AU2002310973A1 (en) | 2002-10-08 |
WO2002077073A3 (en) | 2003-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1265653B1 (en) | Use of polyphosphazene derivatives for antibacterial coatings | |
CN100467073C (en) | Implants with a phosphazene-containing coating | |
US5463010A (en) | Hydrocyclosiloxane membrane prepared by plasma polymerization process | |
Charpentier et al. | Surface modification of polyester to produce a bacterial cellulose-based vascular prosthetic device | |
US8992590B2 (en) | Biocompatibility layer and coated objects | |
Böke et al. | Plasma-enhanced chemical vapor deposition (PE-CVD) yields better hydrolytical stability of biocompatible SiOx thin films on implant alumina ceramics compared to rapid thermal evaporation physical vapor deposition (PVD) | |
US20090216104A1 (en) | Use of acid derivatives of fluoropolymers for fouling-resistant surfaces | |
JP2001500408A (en) | EPTFE small diameter vascular grafts with significant patency enhancement via a surface coating containing covalent heparin | |
JP2010533505A (en) | Compositions and devices comprising silicone and certain polyphosphazenes | |
US20160302723A1 (en) | Cross-linked peg polymer coating for improving biocompatibility of medical devices | |
MX2012014719A (en) | Coating formulation for preparing a hydrophilic coating. | |
CA2408997C (en) | Poly-tri-fluoro-ethoxypolyphosphazene coverings and films for medical devices | |
CA2891048A1 (en) | Method for grafting polymers on metallic substrates | |
Lu et al. | Surface-initiated reverse atom transfer radical polymerization (SI-RATRP) for blood-compatible polyurethane substrates | |
WO2002077073A2 (en) | Plastic articles having a polyphosphazene coating | |
KR20050120665A (en) | Coated dental implants | |
JP2024545725A (en) | Composition for surface treatment of polymeric materials, kit and surface treatment method | |
HK1055910B (en) | Polyphosphazene derivatives having bacterial resistance and use thereof | |
AU2006252063A1 (en) | Implants with a phosphazene-containing coating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |